Published in Pharmacopsychiatry on November 01, 1995
A simple quantitative method for analyzing electrographic status epilepticus in rats. J Neurophysiol (2009) 1.18
Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med (2001) 5.94
Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab (2001) 2.97
Association of hypertension and sleep-disordered breathing. Arch Intern Med (2000) 2.95
Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab (2005) 2.46
Chronic insomnia and activity of the stress system: a preliminary study. J Psychosom Res (1998) 2.06
Sleep apnoea in a hypertensive population. Lancet (1984) 1.90
Short sleep duration and obesity: the role of emotional stress and sleep disturbances. Int J Obes (Lond) (2008) 1.86
Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime. Metabolism (2002) 1.71
Insomnia in central Pennsylvania. J Psychosom Res (2002) 1.71
Adverse events after triazolam substitution. Lancet (1993) 1.64
Effects of nadolol on blood pressure, sleep efficiency, and sleep stages. Clin Pharmacol Ther (1988) 1.35
Severe obstructive sleep apnea--II: Associated psychopathology and psychosocial consequences. J Chronic Dis (1985) 1.33
Periodic leg movements in sleep in essential hypertension. Psychiatry Clin Neurosci (1997) 1.24
Biopsychobehavioral correlates of insomnia, V: Clinical characteristics and behavioral correlates. Am J Psychiatry (1984) 1.22
Narcolepsy-cataplexy. I. Clinical and electrophysiologic characteristics. Arch Neurol (1982) 1.13
Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines. Clin Pharmacol Ther (1991) 1.11
Sleep in the Prader-Willi syndrome. Clinical and polygraphic findings. Arch Neurol (1984) 1.01
Differences in nocturnal and daytime sleep between primary and psychiatric hypersomnia: diagnostic and treatment implications. Psychosom Med (2000) 1.00
Sleep apneic activity in a normal population. Res Commun Chem Pathol Pharmacol (1982) 1.00
Narcolepsy/cataplexy. IV: Diagnostic value of daytime nap recordings. Acta Neurol Scand (1987) 0.99
Quazepam and flurazepam: long-term use and extended withdrawal. Clin Pharmacol Ther (1982) 0.99
Sleep disorders: sleep apnea and narcolepsy. Ann Intern Med (1987) 0.96
Biopsychobehavioral correlates of insomnia, part 1: Role of sleep apnea and nocturnal myoclonus. Psychosomatics (1982) 0.92
Middle-aged men show higher sensitivity of sleep to the arousing effects of corticotropin-releasing hormone than young men: clinical implications. J Clin Endocrinol Metab (2001) 0.91
Nocturnal myoclonus and nocturnal myoclonic activity in the normal population. Res Commun Chem Pathol Pharmacol (1982) 0.91
Alprazolam: effects on sleep and withdrawal phenomena. J Clin Pharmacol (1987) 0.90
Severe obstructive sleep apnea--I: Onset, clinical course, and characteristics. J Chronic Dis (1985) 0.89
Hypnic headache associated with stage 3 slow wave sleep. Headache (2000) 0.88
Nocturnal sleep and wakefulness: effects of age and sex in normal sleepers. Int J Neurosci (1984) 0.87
Rapid eye movement sleep correlates with the overall activities of the hypothalamic-pituitary-adrenal axis and sympathetic system in healthy humans. J Clin Endocrinol Metab (1997) 0.86
Usefulness of polysomnographic studies in the differential diagnosis of insomnia. Int J Neurosci (1995) 0.84
Sleep apneic activity in older healthy subjects. J Appl Physiol (1985) (1985) 0.83
Comparison of short and long half-life benzodiazepine hypnotics: triazolam and quazepam. Clin Pharmacol Ther (1986) 0.83
Midazolam: dose-response studies of effectiveness and rebound insomnia. Pharmacology (1983) 0.82
Quazepam and temazepam: effects of short- and intermediate-term use and withdrawal. Clin Pharmacol Ther (1986) 0.82
Brotizolam: a sleep laboratory evaluation. Eur J Clin Pharmacol (1983) 0.82
Benzodiazepine types in high versus therapeutic dose dependence. Addiction (1996) 0.81
Daytime sleepiness and REM abnormalities in Prader-Willi syndrome: evidence of generalized hypoarousal. Int J Neurosci (1996) 0.81
Sleep-related respiratory disorders. Semin Neurol (1987) 0.80
[Insomnia and quality of sleep among primary care physicians: a gender perspective]. Rev Neurol (2008) 0.79
DSM-III-R co-morbidity in benzodiazepine dependence. Addiction (1999) 0.78
Prader-Willi syndrome: effects of weight loss on sleep-disordered breathing, daytime sleepiness and REM sleep disturbance. Acta Paediatr (1995) 0.78
Sleepwalking and night terrors in adulthood clinical EEG findings. Clin Electroencephalogr (1980) 0.77
Allergic and toxic reaction to alprazolam. Postgrad Med J (1995) 0.77
Narcolepsy/cataplexy. III: Nocturnal sleep and wakefulness patterns. Int J Neurosci (1986) 0.77
Nocturnal sleep and blood pressure in essential hypertension. Int J Neurosci (1988) 0.76
Environmental factors in the development of narcolepsy with cataplexy. A case-control study. Rev Neurol (2015) 0.76
Triazolam. Narrow safety margin is unacceptable. BMJ (1993) 0.75
Triazolam safety. Lancet (1993) 0.75
Zonisamide versus diazepam in the treatment of alcohol withdrawal syndrome. Pharmacopsychiatry (2010) 0.75
Narcolepsy-cataplexy and loss of sphincter control. Postgrad Med J (1996) 0.75
Normal sleep: patterns and mechanisms. Semin Neurol (1987) 0.75
Effects of flurazepam (Dalmane) on anterior pituitary secretion. Res Commun Chem Pathol Pharmacol (1976) 0.75
Delta sleep-inducing peptide in normal humans and in patients with sleep apnea and narcolepsy. Peptides (1995) 0.75
Cannabis and cerebral hemispheres: a chrononeuropsychological study. Int J Neurosci (1991) 0.75
Treatment of sleep disorders IV: Sleep apnea. Ration Drug Ther (1983) 0.75
Porphyria and panic disorder with agoraphobia. Psychosomatics (1994) 0.75
Methylphenidate in stimulants abuse: three case reports. Am J Addict (2001) 0.75
Behavioral side effects of benzodiazepine hypnotics. Clin Neuropharmacol (1985) 0.75
Biopsychobehavioral correlates of insomnia, III: Polygraphic findings of sleep difficulty and their relationship to psychopathology. Int J Neurosci (1984) 0.75
Daytime consumption of triazolam. Acta Psychiatr Scand (1993) 0.75
Sleep disorders in children. Psychiatr Med (1986) 0.75
Sleep in psychiatric disorders. Psychiatr Med (1986) 0.75
Diazepam: effects on sleep and withdrawal phenomena. J Clin Psychopharmacol (1988) 0.75
Treatment of sleep disorders III: Enuresis, sleepwalking, night terrors and nightmares. Ration Drug Ther (1983) 0.75